Follow

Newsletter

MolecularCloud issues the monthly newsletter to promote latest news and research advances from Cloud Scientists.

Gene and cell therapy (GCT) is one of the most competitive emerging fields in global biotechnology. As a new strategy for treating malignant tumors and other human diseases, GCT has been extensively studied in worldwide research and clinical trials since the late 20th century with ...Learn More


Despite decades of clinical efforts in the quest for a cure, Alzheimer’s disease (AD) and other dementias continue to be the most common neurodegenerative diseases in the elderly, affecting approximately 50 million living people worldwide (WHO, 2020). Hundreds of clinical trials ...Learn More


As one of the commonest contributors to human death, cancer has always been a key research area for scientists from all over the world. In a recently published Perspective in Nature Reviews Clinical Oncology, researchers from the International Agency for Research on Cancer predict ...Learn More


Imagine being vaccinated against influenza with a single visit to your doctor. She simply gives you a “magic shot” and then tells you that you won’t see her again, at least not for flu, for the rest of your life. Sound like a Disney movie? Don’t tell Dr. Masaru Kanekiyo ...Learn More


With hundreds of on-going clinical trials and 5 FDA-approved drugs to date, CAR-T cell therapy is one of the most attractive immunotherapies that have got the most attention and advanced the furthest in clinical development. Nevertheless, despite remarkable success in the ...Learn More


About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2021 MolecularCloud